Skip to main content
TipRanks
Go Ultimate75% OFF
Sift Biosciences logo

Sift Biosciences: Valuation, Funding & Investors

San Carlos, CA 94070, UShttps://siftbio.com/Therapeutics

Sift Biosciences is developing a peptide-based immunotherapy platform designed to harness pre-existing immune memory. The company aims to activate memory T cells to generate more consistent immune engagement, with applications across oncology and autoimmune diseases and an initial focus on immunologically cold solid tumors such as microsatellite-stable colorectal and ovarian cancers.

Leadership & Board

Current Number of Employees
10
Current LinkedIn Followers
1,312

Latest Estimated Valuation

Total Amount Raised
$4M
Total Funding Rounds
1
Latest Funding Amount
$4M
Latest Funding Round
Pre-Seed

Employee Trend

Sift Biosciences had 10 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

10Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Sift Biosciences had 1,312 followers as of November 16, 2026. The number of followers increased by 11 (0.85%) week-over-week.

1,312Latest Followers Count
11(0.85%)Week-Over-Week Change
05001,0001,5002,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Feb 18, 2026Pre-Seed$3.70M―

Investors

Investor NameFunding Round
Eisai InnovationPre-Seed
Freeflow VenturesPre-Seed
LifeSpan Vision VenturesPre-Seed
SBI US Gateway FundPre-Seed
Valuence VenturesPre-Seed

Similar Companies

A snapshot of private companies similar to Sift Biosciences, helping you discover and navigate related company profiles.

Related News and Analysis